Jill M. Quigley, Director at Terns Pharmaceuticals, Inc. (TERN), sold 23,760 shares at $5.79 ($137K) on 2025-01-06, disclosed to the SEC on 2025-01-06.
Scheduled sale ($137k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.72 | 6,240 | $36K | 26.0% |
| 2 | $5.79 | 8,760 | $51K | 37.0% |
| 3 | $5.79 | 8,760 | $51K | 37.0% |
| Total | $5.77 avg | 23,760 | $137K | 100% |
| Filing → |
| TERN | SELL | 2024-08-05 | $180K | — | Filing → |
| TERN | SELL | 2024-07-17 | $148K | — | Filing → |
| PASG | SELL | 2021-01-22 | $39K | — | Filing → |